Iran war impact: Essential drugs may cost up to 5% more, for now

The immediate net consumer impact could be 3-5% higher prices, or roughly similar to what consumers paid before the late-September cuts in GST rates. The industry expects the price increase to be in place for 3-4 months, with a rollback option once input costs stabilise.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/eh2Jf8A
via IFTTT

Read More

KKR-backed Baby Memorial to acquire 60% stake in Star Hospitals for ₹1,800 crore

Baby Memorial Hospital will acquire around 60% stake in the Hyderabad hospital chain's parent company, Unimed Healthcare.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/c2ByIzk
via IFTTT

Read More

PM's AYUSH Premium Mark push sparks rise in global demand for 'Made in India' homeopathy: Experts

India's homeopathy sector is experiencing a significant surge in demand, both domestically and internationally. This growth is attributed to the government's AYUSH Premium Mark and NABL accreditation initiatives, which have enhanced quality assurance and global credibility for "Made in India" medicines. These certifications are fostering trust and enabling Indian companies to compete effectively in regulated markets.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/CJG1U4F
via IFTTT

Read More

Bajaj Group enters healthcare: Rs 2,500 crore investment for integrated network

The Bajaj Group is entering the healthcare sector with an initial investment of Rs 2,000-2,500 crore to build Bajaj Integrated Health Systems (BIHS). This new entity will focus on an integrated continuum of care, including hospitals, day clinics, and home services, aiming for a pan-India footprint within 10-15 years.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Fvcnxb7
via IFTTT

Read More

Marengo Asia Hospitals aims to raise ₹500 cr via 10% stake sale

Marengo Asia Hospitals is seeking to raise ₹500 crore by selling a 10% stake, valuing the company at approximately ₹5,000 crore. The hospital chain, backed by Samara Capital and promoter families of Godrej and Havells India, operates eight hospitals across multiple regions. The funds will be used to further expand its network through acquisitions.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Km6eEhx
via IFTTT

Read More

India Pharma 2026 event: Nadda lays out road map for India to take global pharma leadership role

India Pharma Conference: India is set to become a global leader in advanced medicines like biologics and biosimilars, Union Minister J P Nadda said, underlining the need for stronger research and investment. The government is implementing initiatives like Biopharma SHAKTI and PLI schemes to boost domestic manufacturing and self-reliance, he further said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/5mztojw
via IFTTT

Read More

Jhunjhunwalas-backed IKS healthcare looks to acquire TruBridge for $600 million

Nasdaq-listed company will be largest buyout for tech company till date. Will give boost for revenue cycle management offerings.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/yDOeBAi
via IFTTT

Read More